Inventor · disambiguated record
Michel Claude Vellard
Also filed as: VELLARD MICHEL C · VELLARD MICHEL CLAUDE
16 granted patents·9 pending applications·380 citations·filing 2006–2022
94Inventor score
Files withBIOMARIN PHARM INC17ULTRAGENYX PHARMACEUTICAL INC4WENDT DANIEL J2KOPPAKA VISH1VELLARD MICHEL CLAUDE1
Top patents by PatentIndex Score
25 records- 0198US7531341B1Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2006·Granted May 12, 2009·87 cites·6 claims
- 0297US7534595B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2007·Granted May 19, 2009·79 cites·34 claims
- 0396US7560263B2Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereofBIOMARIN PHARM INC·Filed 2008·Granted Jul 14, 2009·81 cites·26 claims
- 0494US8198242B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2010·Granted Jun 12, 2012·46 cites·17 claims
- 0592US8128925B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofVELLARD MICHEL CLAUDE·Filed 2009·Granted Mar 6, 2012·38 cites·29 claims
- 0690US8598121B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2012·Granted Dec 3, 2013·15 cites·14 claims
- 0789US10934534B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofBIOMARIN PHARM INC·Filed 2020·Granted Mar 2, 2021·2 cites·29 claims
- 0888USRE48267EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2017·Granted Oct 20, 2020·2 cites·76 claims
- 0987US7722865B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofBIOMARIN PHARM INC·Filed 2009·Granted May 25, 2010·15 cites·20 claims
- 1080US11505790B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2019·Granted Nov 22, 2022·1 cites·14 claims
- 1180US10221408B2Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2016·Granted Mar 5, 2019·3 cites·18 claims
- 1278US8940513B2Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereofBIOMARIN PHARM INC·Filed 2014·Granted Jan 27, 2015·3 cites·20 claims
- 1378US8765437B2Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereofKOPPAKA VISH·Filed 2011·Granted Jul 1, 2014·6 cites·13 claims
- 1478US2023127775A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1577US12188058B2Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereofBIOMARIN PHARM INC·Filed 2021·Granted Jan 7, 2025·0 cites·1 claims
- 1676US2024035013A1Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 1775US9567572B2Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereofBIOMARIN PHARM INC·Filed 2014·Granted Feb 14, 2017·2 cites·19 claims
- 1871US2019183985A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 1969US2021228694A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 2063US2017119861A1Methods and compositions for the treatment of amyloidosisULTRAGENYX PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 2159US2017051033A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2016·Application pending·0 cites
- 2256USRE46707EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2015·Granted Feb 13, 2018·0 cites·17 claims
- 2354US2016256553A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2015·Application pending·0 cites
- 2451US2013039898A1Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereofBIOMARIN PHARM INC·Filed 2011·Application pending·0 cites
- 2539US2010261252A1Methods of enhancing yield of active iga proteaseBIOMARIN PHARM INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel Claude Vellard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →